Recent incidence and descriptive epidemiological survey of breast cancer in Saudi Arabia

References

1. ↵
   1. Brown R,
   2. Kerr K,
   3. Haoudi A,
   4. Darzi A

   (2012) Tackling cancer burden in the Middle East: Qatar as an example. Lancet Oncol 13:e501–e508.

   OpenUrlCrossRefPubMedWeb of Science
2. 1. Othman A,
   2. Ahram M,
   3. Al-Tarawneh MR,
   4. Shahrouri M

   (2015) Knowledge, attitudes and practices of breast cancer screening among women in Jordan. Health Care Women Int 36:578–592.

   OpenUrl
3. 1. Al-Saad S,
   2. Al-Shinnawi H,
   3. Mahmood Shamsi N

   (2009) Risk Factors of Breast Cancer in Bahrain. Bahrain Medical Bulletin 31:1–11.

   OpenUrl
4. ↵
   1. Miller AB

   (2010) Screening for breast cancer in the Eastern Mediterranean Region. East Mediterr Health J 16:1022–1024.

   OpenUrlPubMed
5. ↵
   1. Baron-Epel O,
   2. Friedman N,
   3. Lernau O

   (2009) Reducing disparities in mammography-use in a multicultural population in Israel. Int J Equity Health 8:19.

   OpenUrlPubMed
6. ↵
   1. Bener A,
   2. El Ayoubi HR,
   3. Moore MA,
   4. Basha B,
   5. Joseph S,
   6. Chouchane L

   (2009) Do we need to maximise the breast cancer screening awareness? Experience with an endogamous society with high fertility. Asian Pac J Cancer Prev 10:599–604.

   OpenUrlPubMed
7. ↵
   1. Cohen M,
   2. Azaiza F

   (2010) Increasing breast examinations among arab women using a tailored culture-based intervention. Behav Med 36:92–99.

   OpenUrlCrossRefPubMed
8. ↵
   1. Keten HS,
   2. Yıldırım F,
   3. Ölmez S,
   4. Üçer H,
   5. Çelik M

   (2014) Knowledge, attitudes and behavior about breast cancer in women presenting to Early Cancer Diagnosis, Screening and Education Centre in Kahramanmaraş, Turkey. Gaziantep Medical Journal 20:212–216.

   OpenUrl
9. 1. Kawar LN

   (2009) Jordanian and Palestinian immigrant women’s knowledge, affect, cultural attitudes, health habits, and participation in breast cancer screening. Health Care Women Int 30:768–782.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Azaiza F,
    2. Cohen M,
    3. Awad M,
    4. Daoud F

    (2010) Factors associated with low screening for breast cancer in the Palestinian Authority: relations of availability, environmental barriers, and cancer-related fatalism. Cancer 116:4646–4655.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Yousuf SA

    (2010) Breast Cancer Awareness among Saudi Nursing Students. Journal of King Abdulaziz University Medical Sciences 17:67–78.

    OpenUrl
12. ↵
    1. Brandt J,
    2. Garne JP,
    3. Tengrup I,
    4. Manjer J

    (2015) Age at diagnosis in relation to survival following breast cancer: a cohort study. World J Surg Oncol 13:33.

    OpenUrl
13. 1. Arce-Salinas C,
    2. Aguilar-Ponce JL,
    3. Villarreal-Garza C,
    4. Lara-Medina FU,
    5. Olvera-Caraza D,
    6. Alvarado Miranda A,
    7. et al.

    (2014) Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients. Breast Cancer Res Treat 146:183–188.

    OpenUrlCrossRefPubMed
14. 1. Papageorgiou EI,
    2. Jayashree Subramanian,
    3. Karmegam A,
    4. Papandrianos N

    (2015) A risk management model for familial breast cancer: A new application using Fuzzy Cognitive Map method. Comput Methods Programs Biomed, pii: S0169-2607(15)00180-7.
15. 1. Alvarez K

    Oral Contraceptive Androgenicity and Cognitive Performance Among Women (Doctoral dissertation, Drexel University), Available from:https://idea.library.drexel.edu/islandora/object/idea%3A4454/datastream/OBJ/download/Oral_Contraceptive_Androgenicity_and_Cognitive_Performance_Among_Women.pdf.
16. 1. Kiely D,
    2. Schwartz S

    (2014) Assessing breast cancer risk in a primary care setting. The Nurse Practitioner 39:49–53.

    OpenUrl
17. ↵
    1. Uday CK,
    2. Devarayalu BVSK,
    3. Mahmood S

    (2010) Overall survival rate in breast cancer patients treated with 5-fluorouracil: a review of randomized clinical trials. Int J Pharmaceut Biomed Res 1:132–135.

    OpenUrl
18. ↵
    1. Waters EA,
    2. McNeel TS,
    3. Stevens WM,
    4. Freedman AN

    (2012) Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat 134:875–880.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    1. Schroyen S,
    2. Adam S,
    3. Jerusalem G,
    4. Missotten P

    (2014) Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads. Clin Interv Aging 10:117–125.

    OpenUrlPubMed
20. ↵
    1. Wang AT,
    2. Vachon CM,
    3. Brandt KR,
    4. Ghosh K

    (2014) Breast Density and Breast Cancer Risk: A Practical Review. Mayo Clinic Proceedings 89:548–557.

    OpenUrlCrossRefPubMed
21. ↵
    1. Postma EL,
    2. van Hillegersberg R,
    3. Daniel BL,
    4. Merckel LG,
    5. Verkooijen HM,
    6. van den Bosch MA

    (2011) MRI-guided ablation of breast cancer: where do we stand today? J Magn Reson Imaging 34:254–261.

    OpenUrlPubMed
22. ↵
    1. Domanski HA

    1. Geijer M,
    2. Domanski HA

    (2014) in Atlas of Fine Needle Aspiration Cytology, Image-Guided Fine-Needle Aspiration Cytology, ed Domanski HA (Springer, London (UK)), 2014 ed, pp 35–46.
23. ↵
    1. Sung H,
    2. Rosenberg PS,
    3. Chen WQ,
    4. Hartman M,
    5. Lim WY,
    6. Chia KS,
    7. et al.

    (2015) Female breast cancer incidence among Asian and Western populations: more similar than expected. J Natl Cancer Inst 107:pii: djv107.
24. ↵
    1. Alghamdi IG,
    2. Hussain II,
    3. Alghamdi MS,
    4. El-Sheemy MA

    (2013) The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008. Breast Cancer (Dove Med Press) 5:103–109.

    OpenUrl
25. ↵
    1. Molah Karim SA,
    2. Ali Ghalib HH,
    3. Mohammed SA,
    4. Fattah FH

    (2015) The incidence, age at diagnosis of breast cancer in the Iraqi Kurdish population and comparison to some other countries of Middle-East and West. Int J Surg 13:71–75.

    OpenUrl